Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment.
Saved in:
| Title: | Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment. |
|---|---|
| Authors: | Aamer, Hadega A.1,2 (AUTHOR), McClure, Jan3 (AUTHOR), Ko, Daisy1 (AUTHOR), Maenza, Janine4 (AUTHOR), Collier, Ann C.4 (AUTHOR), Coombs, Robert W.2,3,4 (AUTHOR), Mullins, James I.2,3,4,5 (AUTHOR), Frenkel, Lisa M.1,2,3,4,6 (AUTHOR) lfrenkel@uw.edu |
| Source: | PLoS Pathogens. 8/25/2020, Vol. 16 Issue 8, p1-24. 24p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 15537366 |
|---|---|
| DOI: | 10.1371/journal.ppat.1008791 |
